Sacubitril-valsartan modifies the indication of cardiac implantable devices in patients with heart failure and reduced ejection fraction

Document Type: Article

Version: Accepted version

Date: 2021

• Description
• View document

Name: Belarte_rec_sacu.pdf

Size: 1.199Mb

Format: PDF

View/Open

Citation: Belarte-Tornero LC, Mojón D, Solé-González E, Ruiz-Bustillo S, Valdivielso-More S, Farré N. Sacubitril-valsartan modifies the indication of cardiac implantable devices in patients with heart failure and reduced ejection fraction. Rev Esp Cardiol (Engl Ed). 2021 Dec;74(12):1117-9. DOI: 10.1016/j.rec.2021.06.005

Permanent link: http://hdl.handle.net/10230/53629

Author: Belarte Tornero, Laia Carla ; Mojón Álvarez, Diana ; Solé-González, Eduard ; Ruiz-Bustillo, Sonia ; Valdivielso Moré, Sandra ; Farré López, Núria

DOI: http://dx.doi.org/10.1016/j.rec.2021.06.005

Show full item record

This item appears in the following Collection(s)

• Articles (Hospital del Mar Research Institute): 5004